Shattuck Labs, Inc.

NasdaqGS STTK

Shattuck Labs, Inc. Share Price on January 14, 2025: USD 1.12

Shattuck Labs, Inc. Share Price is USD 1.12 on January 14, 2025, a -86.84% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Shattuck Labs, Inc. 52-week high Share Price is USD 11.18 on May 06, 2024, which is 898.21% above the current Share Price.
Shattuck Labs, Inc. 52-week low Share Price is USD 1.00 on November 22, 2024, which is -10.71% below the current Share Price.
Shattuck Labs, Inc. average Share Price for the last 52 weeks is USD 5.26.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqGS: STTK

Shattuck Labs, Inc.

CEO	Dr. Taylor H. Schreiber M.D., Ph.D.
IPO Date	Oct. 9, 2020
Location	United States
Headquarters	500 West 5th Street
Employees	75
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals

Description

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Key trends

Past 5 years